For three years, staffers at UCLA Health have been quietly fulfilling final wishes for dying patients in the intensive care unit. Amid the isolating forces of the pandemic, their work has become all the more meaningful.
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos.
The pandemic has forced millions of families to weigh the risks of vulnerable grandparents getting too close to their beloved grandchildren — against the heartache of staying away.
A possibility that the blood of people who had COVID could save others has set off a mad scramble for donors — with top-dollar offers and a plan that relies on the blood of 10,000 Orthodox Jewish women.
Public officials are putting high hopes on new blood tests as a means of determining who has developed antibodies to COVID-19, and with those antibodies, presumed immunity. But experts caution the tests are largely unreliable and the science is still catching up.
Funcionarios de la Organización Mundial de la Salud se manifestaron en contra de los planes de algunos países de tener “pasaportes de inmunidad”, que habilitarían a salir y trabajar.
En todo los Estados Unidos, COVID-19 está alterando radicalmente la atención médica, no solo para los adultos mayores vulnerables sino también para las embarazadas y sus recién nacidos.
COVID-19 is changing medical care, not only for vulnerable elders but also for pregnant women and their babies entering the world.
As efforts ramp up to collect blood plasma from the first survivors of COVID-19, families of critically ill patients are jockeying to obtain the still-unproven antibody treatment.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
New guidelines issued Tuesday could speed a century-old therapy to those critically ill with the pandemic virus.
Barbara Dreyfuss died March 1 after contracting COVID-19 at a Seattle-area nursing home. Her earlier decision to document her final wishes may offer an example for families as the deadly virus spurs interest in end-of-life care.
Se están promoviendo los funerales en internet, tomando precauciones extra al atender los cuerpos, y pidiendo que los servicios sean breves y con pocas personas. Un luto distinto.
As the novel coronavirus marches across the country, it is upending how families and funeral homes honor the dead — and, ultimately, put them to rest.
Los doctores Keith Jerome y Alex Greninger, de la Universidad de Washington, han supervisado la implementación de más de 4,000 pruebas de pacientes de todo el país.
Drs. Keith Jerome and Alex Greninger fast-tracked a test for the deadly new coronavirus weeks before it began spreading in the U.S. Their work has been key to detecting community transmission and ramping up the nation’s testing capacity.
Los bancos necesitan tener una reserva de sangre de al menos dos o tres días, pero algunos tienen sólo para un día por las cancelaciones y la falta de donantes.
Cancellations and no-shows for blood drives in states where the virus is spreading — and in ones where it’s not — pose risks for the nation’s inventories.
The spread of coronavirus disease to a skilled nursing facility in Washington state underscores the risk the deadly new virus poses in elder care facilities, where illnesses caused by more common pathogens, like seasonal influenza, often spread rapidly.
En los Estados Unidos, 2.2 millones de personas viven en entornos de atención a largo plazo y pueden estar en mayor riesgo debido a la edad y a condiciones de salud subyacentes.